To receive the Femtech World newsletter, sign up here.
News
Biotech start-up raises US$33m to develop new fertility treatments
The financing will support the clinical development of Gameto’s novel investigational in vitro maturation (IVM) solution in the US

The US biotech start-up Gameto has raised US$33m in Series B funding to advance the development and commercialisation of new fertility treatments.
Gameto works towards developing a product suite to support women in need of fertility treatment.
The company’s lead programme, Fertilo, aims to make IVF and egg freezing shorter, safer and more accessible through reduced hormonal injections by maturing eggs outside of the body.
This latest funding, led by Two Sigma Ventures with RA Capital and participation from existing investors, brings Gameto’s total capital raised to US$73m. The financing is hoped to support the clinical development of Fertilo in the US.
Following productive discussions with the US Food and Drug Administration (FDA), Gameto received tentative approval to proceed to Phase 3 trials, subject to the completion of certain assay and manufacturing requirements.
The funding will also support the commercial launches of Fertilo in Australia and Latin America where the solution is already being used.
“I am proud of the strong scientific foundation, driven and high performing team, innovative pipeline and encouraging data that we have cultivated at Gameto, and I am incredibly excited to amplify and build upon this momentum with the addition of leading investors with extensive expertise in reproductive medicine,” said Dr Dina Radenkovic, co-founder and CEO of Gameto.
“These funds will support our late stage clinical development in the US, post-market surveillance outside the US and the creation of a commercial operations function.
“We are honoured to have added the teams at Two Sigma, RA Capital, and others to our stellar investor base, and we’re pleased to see increased investor confidence in our platform technology and a recognition of the pressing need for modern treatments in the historically underfunded women’s health space, despite a challenging market.
“I believe that each small step we take in investing in women’s health can lead to a giant leap in medical breakthroughs and innovation.”
Dusan Perovic, partner at Two Sigma Ventures, said: “Gameto’s pioneering approach to IVF has the potential to impact families and societies on a global scale.
“In addition to making treatments much easier and more accessible for women, Gameto’s advanced IVF/egg-freezing solution addresses a massive societal need as we’re living longer and looking to start families later in life while facing rising female and male infertility rates.
“There’s also a growing demand for IVF from a broader group of people, such as those with certain genetic disorders now discoverable by carrier screening, and single and same-sex parents starting families, to name a few.
“By harnessing cutting-edge breakthroughs in genetic sequencing and cellular engineering – tools that didn’t exist until recently – Gameto is poised to upend traditional IVF treatments to make them more accessible, convenient, and faster for anyone to start a family.”
Laura Stoppel, principal at RA Capital Management, shared: “It’s astounding how little innovation has gone into improving IVF over the past 45 years.
“Gameto is a pioneer in the women’s health industry, and we believe Fertilo represents a much-needed option for women as they navigate their fertility journey.”
Peter Kolchinsky, managing partner of RA Capital Management, added: “This investment is among the most personal any investor can make.
“Many at our firm have been blessed by what IVF makes possible, and know the ordeal that women tolerate at the outset of that journey just to conceive.
“To contemplate the importance of easing that burden, of expanding the freedom of many to have children when they are ready, it’s hard to overestimate the potential impact of such an advance on humanity, for all of our society, for the rest of time.”
Menopause
AI maps how reproductive organs age differently during menopause
Cancer
Ovarian cancer cases rising among younger adults, study finds

Ovarian cancer cases are rising among younger adults in England, with bowel cancer showing a similar pattern, a new study suggests.
Researchers said excess weight is a key contributor, but is unlikely on its own to explain the pattern.
The authors wrote: “These patterns suggest that while similar risk factors across ages are likely, some cancers may have age-specific exposures, susceptibilities, or differences in screening and detection practices.”
They added: “Although overweight and obesity are linked to 10 of the 11 cancers evaluated and account for a substantial proportion of cancer cases, both BMI-attributable and BMI-non-attributable incidence rates have increased, though the latter more slowly, suggesting other contributors.”
The study analysed cancer incidence, meaning new diagnoses, in England between 2001 and 2019 across more than 20 cancer types, comparing adults aged 20 to 49 with those aged 50 and over.
Among younger women, cases of 16 out of 22 cancers increased significantly over the period, while among younger men, 11 out of 21 cancers increased significantly.
In particular, there was a significant rise in 11 cancers with known behavioural risk factors among adults under 50. These were thyroid, multiple myeloma, liver, kidney, gallbladder, bowel, pancreatic, endometrial, mouth, breast and ovarian cancers.
Rates of all 11 also rose significantly among adults aged 50 and over, with the notable exceptions of bowel and ovarian cancer.
Five cancers, endometrial, kidney, pancreatic, multiple myeloma and thyroid cancer, increased significantly faster in younger than in older women, while multiple myeloma increased faster in younger than in older men.
The researchers looked at established risk factors including smoking, alcohol intake, diet, physical inactivity and body mass index, a measure used to assess whether someone is underweight, a healthy weight, overweight or obese.
With the exception of mouth cancer, all 11 cancers were associated with obesity. Six, liver, bowel, mouth, pancreatic, kidney and ovarian, were also linked to smoking.
Four, liver, bowel, mouth and breast, were associated with alcohol intake. Three, bowel, breast and endometrial, were linked to physical inactivity, and one, bowel, was associated with dietary factors.
But apart from excess weight, trends in those risk factors over the past one to two decades were stable or improving among younger adults.
That suggests other factors may also play a part, including reproductive history, early-life or prenatal exposures, and changes in diagnosis and detection.
The study noted that red meat consumption fell among younger adults, while fibre intake remained stable or slightly improved in both sexes between 2009 and 2019, although more than 90 per cent of younger adults were still not eating enough fibre in 2018.
Established behavioural risk factors accounted for a substantial share of cancer cases.
Excess weight was the risk factor associated with most cancers in 2019, ranging from 5 per cent for ovarian cancer to 37 per cent for endometrial cancer.
The researchers said the findings were based on observational data, meaning the study could identify patterns but could not prove cause and effect.
They also noted there were no consistent long-term national data for several risk factors, that the analysis was limited to England rather than the UK, and that cancer remains far more common overall in older adults despite the rise in cases among younger people.
Pregnancy
Early miscarriage care could prevent 10,000 pregnancy losses a year, study finds
Entrepreneur7 days agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
Entrepreneur4 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Pregnancy4 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
News4 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Diagnosis2 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Mental health1 week agoLifting weights shows mental health and cognitive benefits in older women, study finds
Menopause2 weeks agoMore research needed to understand link between brain fog and menopause, expert says
News4 weeks agoCopper coil vs Mirena: Which is right for you?















8 Comments